Exponent's premium scientific and engineering consulting franchise is countercyclical, with litigation and product recall work providing defensive revenue. Reactive work has slowed in 2025, while proactive consulting (battery safety, AI risk) is growing. Margin profile and utilization remain industry-leading. Limited near-term catalysts; quality compounder at fair value.
| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| EXPO | Exponent Inc. | 59 | +6% | ↓6% | NEUTRAL |
| ERJ | Embraer SA | 59 | +13% | ↓6% | EARLY |
| UNP | Union Pacific Corporation | 59 | +7% | ↓6% | EARLY |
| NSC | Norfolk Southern Corporation | 59 | +3% | ↓6% | NEUTRAL |
| IR | Ingersoll Rand Inc. | 59 | +9% | ↓6% | EARLY |
| CARR | Carrier Global Corporation | 59 | +10% | ↓6% | EARLY |
| CAT | Caterpillar Inc. | 59 | +12% | ↓6% | EARLY |
Exponent AI risk consulting practice grows 30% YoY
Reactive litigation engagements normalize in Q1
Estimates · Yahoo Finance · Not audited figures